Clinical Trial: Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07912814) titled 'Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique' on Oct. 28.

Brief Summary: The goal of this clinical study is to learn whether DOT PN (Rejuran S), a polynucleotide injectable gel, improves periorbital hollowing (a sunken look around the eyes) in adults aged 25 to 65 years when injected into the deep layer around the eyes with a blunt cannula. Safety will also be assessed.

The main question it aims to answer is:

- How much do tear trough depth and brow height change from baseline to Week 16, as measured by 3D imaging?

There is no comparison gro...